These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31939321)

  • 61. Phototherapy for hyperbilirubinemia of hemolytic disease of the newborn.
    Maurer HM; Kirkpatrick BV; McWilliams NB; Draper DA; Bryla DA
    Pediatrics; 1985 Feb; 75(2 Pt 2):407-12. PubMed ID: 4038554
    [No Abstract]   [Full Text] [Related]  

  • 62. Prophylactic Phototherapy in ABO Incompatibility.
    Birenbaum HJ
    J Perinatol; 2005 Dec; 25(12):805. PubMed ID: 16311505
    [No Abstract]   [Full Text] [Related]  

  • 63. Decreased response to phototherapy for neonatal jaundice in breast-fed infants.
    Tan KL
    Arch Pediatr Adolesc Med; 1998 Dec; 152(12):1187-90. PubMed ID: 9856427
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mechanisms of hemolysis.
    Zipursky A
    Mead Johnson Symp Perinat Dev Med; 1982; (19):17-24. PubMed ID: 6821465
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Clinico-epidemiologic considerations on 533 jaundiced newborn infants treated with phototherapy].
    Schwarzenberg TL; Canibus Schwarzenberg R; Menghetti E; Traditi M; Acconcia P
    Pediatr Med Chir; 1983; 5(5):341-4. PubMed ID: 6544414
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy of phototherapy and/or exchange transfusions in neonatal jaundice.
    Kalpoyiannis N; Androulakis N; Hadjigerorgiou E; Papadatos J; Oeconomidou O; Nicolopoulos D
    Clin Pediatr (Phila); 1982 Oct; 21(10):602-6. PubMed ID: 7116744
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Management of neonatal jaundice.
    Osborn LM
    Nurse Pract; 1986 Apr; 11(4):41, 44, 49-52. PubMed ID: 3960414
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Time-limited phototherapy of term newborns in ABO hemolytic disease and hyperbilirubinaemia.
    Rosta J; Makoi Z; Békefi D; Várady
    J Perinat Med; 1975; 3(3):198-203. PubMed ID: 1240143
    [TBL] [Abstract][Full Text] [Related]  

  • 69. ABM Clinical Protocol #22: Guidelines for Management of Jaundice in the Breastfeeding Infant 35 Weeks or More of Gestation-Revised 2017.
    Flaherman VJ; Maisels MJ;
    Breastfeed Med; 2017 Jun; 12(5):250-257. PubMed ID: 29624434
    [No Abstract]   [Full Text] [Related]  

  • 70. [Importance of the determination of bilirubin not bound to albumin on a sephadex gel column in neonatal jaundice].
    Rusu O; Popa M; Nanu R; Taulescu G
    Pediatria (Bucur); 1973; 22(1):75-82. PubMed ID: 4798769
    [No Abstract]   [Full Text] [Related]  

  • 71. [Importance of the determination of bilirubin not bound to albumin on a sephadex gel column in neonatal jaundice].
    Rusu O; Popa M; Nanu R; Taulescu G
    Pediatria (Bucur); 1973; 22(1):75-82. PubMed ID: 4739035
    [No Abstract]   [Full Text] [Related]  

  • 72. [Closed system exchange transfusion of newborn infants (data from 1966 to 1970)].
    Kora'nyi D; Pesthi E
    Pediatriia; 1972 Jun; 51(6):58-62. PubMed ID: 4626061
    [No Abstract]   [Full Text] [Related]  

  • 73. ABO hemolytic disease of the fetus and newborn: thirteen years of data after implementing a universal bilirubin screening and management program.
    Christensen RD; Baer VL; MacQueen BC; O'Brien EA; Ilstrup SJ
    J Perinatol; 2018 May; 38(5):517-525. PubMed ID: 29410540
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Fototherapy of neonatal hyperbilirubinemia. Results of its clinical application (author's transl)].
    Hohenauer L; Haschke F; Gerstl JW
    Klin Padiatr; 1976 Jul; 188(4):314-9. PubMed ID: 988423
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Isoagglutinins of the ABO system in universal blood preparations (KU-ABO) used for exchange transfusions in hemolytic disease of the newborn].
    Cwik J
    Pediatr Pol; 1985 Sep; 60(9):652-7. PubMed ID: 3831898
    [No Abstract]   [Full Text] [Related]  

  • 76. Vigintiphobia revisited.
    Watchko JF
    Pediatrics; 2005 Jun; 115(6):1747-53. PubMed ID: 15930239
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Results of 2 prospective surveys on phototherapy of neonatal jaundice in 274 subjects. Study of the influence of light energy intensity and continuous or discontinuous mode of treatment].
    Caldera R; Maigret P; Maynier M; Larbey P; Fermanian J; Dahan R
    Ann Pediatr (Paris); 1984 Apr; 31(4):297-301. PubMed ID: 6430204
    [No Abstract]   [Full Text] [Related]  

  • 78. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
    Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
    Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [The place of determination of unbound bilirubin and serum albumin in the surveillance of jaundice in the premature infant].
    Satge P; Colin J; Voyer M; Crumiere C; Charlas J
    Arch Fr Pediatr; 1974; 31(2):201-13. PubMed ID: 4859164
    [No Abstract]   [Full Text] [Related]  

  • 80. [Place of phototherapy in the treatment of jaundice in the newborn].
    Farriaux JP; Wackenier JP; Blanckaert D; Hongre JF; Sauvage R
    Lille Med; 1973 Apr; 18(4):403-14. PubMed ID: 4795733
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.